ArticleBMJ open2025

Multicentre phase II open study assessing the efficacy and safety of apremilast in children and adults with epidermolysis bullosa simplex generalised: study protocol for the EBULO study.

Eric Fontas et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.